Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06866483 · ClinicalTrials.gov registry record
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
A clinical trial of Myasthenia Gravis and Neuromuscular Manifestations, sponsored by ZS Associates.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06866483: Recruiting study of Myasthenia Gravis and Neuromuscular Manifestations, sponsored by ZS Associates.
NCT06866483 is a study of Myasthenia Gravis and Neuromuscular Manifestations that is actively recruiting participants, run by ZS Associates. The registered enrollment target is 1,000 participants, above the 160-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (525% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06866483, a study of Myasthenia Gravis and Neuromuscular Manifestations, is actively recruiting participants, sponsored by ZS Associates.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).
Primary Outcome
Measure the specificity and sensitivity of the Self-Assessment tool
Conditions Studied
Interventions
- BEHAVIORAL Social media recruitment
- BEHAVIORAL Self-Assessment
- BEHAVIORAL Follow-up
Study Locations (1)
Illinois
- ZS Associates - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2025-12-31 |
What NCT06866483 shows while recruiting
NCT06866483 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 160-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (525% higher).
The record links to 3 conditions, with Myasthenia Gravis appearing as the primary indexed condition, and to 3 interventions - of which Social media recruitment is the first listed.
NCT06866483 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06866483 about?
NCT06866483 is a clinical study titled "Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment". This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-ass...
What is the current status of trial NCT06866483?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-02-26. Estimated completion is 2025-12-31.
What conditions does trial NCT06866483 study?
This clinical trial studies the following conditions: Myasthenia Gravis, Neuromuscular Manifestations, Neuromuscular Disease.
What interventions are being tested in trial NCT06866483?
The interventions under investigation include: Social media recruitment (BEHAVIORAL), Self-Assessment (BEHAVIORAL), Follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT06866483?
This trial is sponsored by ZS Associates, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06866483 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06866483's enrollment target sits among peer trials
1,000 1st of 32 higher than 32 of 32 other Myasthenia Gravis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myasthenia Gravis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI